EMEA (Europe, Middle East and Africa) T Cell Antigen Gp39 Market Report 2017

December 2017 | 105 pages | ID: ED98C99FD8AEN
QYResearch

Abstracts

In this report, the EMEA T Cell Antigen Gp39 market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of T Cell Antigen Gp39 for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA T Cell Antigen Gp39 market competition by top manufacturers/players, with T Cell Antigen Gp39 sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Biogen, Inc.
• Bristol-Myers Squibb Company
• eTheRNA Immunotherapies NV
• ImmuNext, Inc.
• Juno Therapeutics Inc.
• MedImmune, LLC
• Targovax AS
• XL-protein GmbH

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• ECI-006
• Hepatitis B vaccine
• INX-021
• ISF-35
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Graft Versus Host Disease
• Breast Cancer
• Bladder Cancer
• Panceratic Cancer
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) T Cell Antigen Gp39 Market Report 2017

1 T CELL ANTIGEN GP39 OVERVIEW

1.1 Product Overview and Scope of T Cell Antigen Gp39
1.2 Classification of T Cell Antigen Gp39
  1.2.1 EMEA T Cell Antigen Gp39 Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA T Cell Antigen Gp39 Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 ECI-006
  1.2.4 Hepatitis B vaccine
  1.2.5 INX-021
  1.2.6 ISF-35
  1.2.7 Others
1.3 EMEA T Cell Antigen Gp39 Market by Application/End Users
  1.3.1 EMEA T Cell Antigen Gp39 Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Graft Versus Host Disease
  1.3.3 Breast Cancer
  1.3.4 Bladder Cancer
  1.3.5 Panceratic Cancer
  1.3.6 Others
1.4 EMEA T Cell Antigen Gp39 Market by Region
  1.4.1 EMEA T Cell Antigen Gp39 Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of T Cell Antigen Gp39 (2012-2022)
  1.5.1 EMEA T Cell Antigen Gp39 Sales and Growth Rate (2012-2022)
  1.5.2 EMEA T Cell Antigen Gp39 Revenue and Growth Rate (2012-2022)

2 EMEA T CELL ANTIGEN GP39 COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA T Cell Antigen Gp39 Market Competition by Players/Manufacturers
  2.1.1 EMEA T Cell Antigen Gp39 Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA T Cell Antigen Gp39 Revenue and Share by Players (2012-2017)
  2.1.3 EMEA T Cell Antigen Gp39 Sale Price by Players (2012-2017)
2.2 EMEA T Cell Antigen Gp39 (Volume and Value) by Type/Product Category
  2.2.1 EMEA T Cell Antigen Gp39 Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA T Cell Antigen Gp39 Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA T Cell Antigen Gp39 Sale Price by Type (2012-2017)
2.3 EMEA T Cell Antigen Gp39 (Volume) by Application
2.4 EMEA T Cell Antigen Gp39 (Volume and Value) by Region
  2.4.1 EMEA T Cell Antigen Gp39 Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA T Cell Antigen Gp39 Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA T Cell Antigen Gp39 Sales Price by Region (2012-2017)

3 EUROPE T CELL ANTIGEN GP39 (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe T Cell Antigen Gp39 Sales and Value (2012-2017)
  3.1.1 Europe T Cell Antigen Gp39 Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe T Cell Antigen Gp39 Revenue and Growth Rate (2012-2017)
3.2 Europe T Cell Antigen Gp39 Sales and Market Share by Type
3.3 Europe T Cell Antigen Gp39 Sales and Market Share by Application
3.4 Europe T Cell Antigen Gp39 Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe T Cell Antigen Gp39 Sales Volume by Countries (2012-2017)
  3.4.2 Europe T Cell Antigen Gp39 Revenue by Countries (2012-2017)
  3.4.3 Germany T Cell Antigen Gp39 Sales and Growth Rate (2012-2017)
  3.4.4 France T Cell Antigen Gp39 Sales and Growth Rate (2012-2017)
  3.4.5 UK T Cell Antigen Gp39 Sales and Growth Rate (2012-2017)
  3.4.6 Russia T Cell Antigen Gp39 Sales and Growth Rate (2012-2017)
  3.4.7 Italy T Cell Antigen Gp39 Sales and Growth Rate (2012-2017)
  3.4.8 Benelux T Cell Antigen Gp39 Sales and Growth Rate (2012-2017)

4 MIDDLE EAST T CELL ANTIGEN GP39 (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East T Cell Antigen Gp39 Sales and Value (2012-2017)
  4.1.1 Middle East T Cell Antigen Gp39 Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East T Cell Antigen Gp39 Revenue and Growth Rate (2012-2017)
4.2 Middle East T Cell Antigen Gp39 Sales and Market Share by Type
4.3 Middle East T Cell Antigen Gp39 Sales and Market Share by Application
4.4 Middle East T Cell Antigen Gp39 Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East T Cell Antigen Gp39 Sales Volume by Countries (2012-2017)
  4.4.2 Middle East T Cell Antigen Gp39 Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia T Cell Antigen Gp39 Sales and Growth Rate (2012-2017)
  4.4.4 Israel T Cell Antigen Gp39 Sales and Growth Rate (2012-2017)
  4.4.5 UAE T Cell Antigen Gp39 Sales and Growth Rate (2012-2017)
  4.4.6 Iran T Cell Antigen Gp39 Sales and Growth Rate (2012-2017)

5 AFRICA T CELL ANTIGEN GP39 (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa T Cell Antigen Gp39 Sales and Value (2012-2017)
  5.1.1 Africa T Cell Antigen Gp39 Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa T Cell Antigen Gp39 Revenue and Growth Rate (2012-2017)
5.2 Africa T Cell Antigen Gp39 Sales and Market Share by Type
5.3 Africa T Cell Antigen Gp39 Sales and Market Share by Application
5.4 Africa T Cell Antigen Gp39 Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa T Cell Antigen Gp39 Sales Volume by Countries (2012-2017)
  5.4.2 Africa T Cell Antigen Gp39 Revenue by Countries (2012-2017)
  5.4.3 South Africa T Cell Antigen Gp39 Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria T Cell Antigen Gp39 Sales and Growth Rate (2012-2017)
  5.4.5 Egypt T Cell Antigen Gp39 Sales and Growth Rate (2012-2017)
  5.4.6 Algeria T Cell Antigen Gp39 Sales and Growth Rate (2012-2017)

6 EMEA T CELL ANTIGEN GP39 MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Biogen, Inc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 T Cell Antigen Gp39 Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Biogen, Inc. T Cell Antigen Gp39 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bristol-Myers Squibb Company
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 T Cell Antigen Gp39 Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bristol-Myers Squibb Company T Cell Antigen Gp39 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 eTheRNA Immunotherapies NV
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 T Cell Antigen Gp39 Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 eTheRNA Immunotherapies NV T Cell Antigen Gp39 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 ImmuNext, Inc.
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 T Cell Antigen Gp39 Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 ImmuNext, Inc. T Cell Antigen Gp39 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Juno Therapeutics Inc.
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 T Cell Antigen Gp39 Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Juno Therapeutics Inc. T Cell Antigen Gp39 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 MedImmune, LLC
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 T Cell Antigen Gp39 Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 MedImmune, LLC T Cell Antigen Gp39 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Targovax AS
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 T Cell Antigen Gp39 Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Targovax AS T Cell Antigen Gp39 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 XL-protein GmbH
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 T Cell Antigen Gp39 Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 XL-protein GmbH T Cell Antigen Gp39 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview

7 T CELL ANTIGEN GP39 MANUFACTURING COST ANALYSIS

7.1 T Cell Antigen Gp39 Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of T Cell Antigen Gp39

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 T Cell Antigen Gp39 Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of T Cell Antigen Gp39 Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA T CELL ANTIGEN GP39 MARKET FORECAST (2017-2022)

11.1 EMEA T Cell Antigen Gp39 Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA T Cell Antigen Gp39 Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA T Cell Antigen Gp39 Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA T Cell Antigen Gp39 Price and Trend Forecast (2017-2022)
11.2 EMEA T Cell Antigen Gp39 Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe T Cell Antigen Gp39 Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt T Cell Antigen Gp39 Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa T Cell Antigen Gp39 Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA T Cell Antigen Gp39 Sales Forecast by Type (2017-2022)
11.7 EMEA T Cell Antigen Gp39 Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of T Cell Antigen Gp39
Figure EMEA T Cell Antigen Gp39 Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA T Cell Antigen Gp39 Sales Volume Market Share by Type (Product Category) in 2016
Figure ECI-006 Product Picture
Figure Hepatitis B vaccine Product Picture
Figure INX-021 Product Picture
Figure ISF-35 Product Picture
Figure Others Product Picture
Figure EMEA T Cell Antigen Gp39 Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of T Cell Antigen Gp39 by Application in 2016
Figure Graft Versus Host Disease Examples
Table Key Downstream Customer in Graft Versus Host Disease
Figure Breast Cancer Examples
Table Key Downstream Customer in Breast Cancer
Figure Bladder Cancer Examples
Table Key Downstream Customer in Bladder Cancer
Figure Panceratic Cancer Examples
Table Key Downstream Customer in Panceratic Cancer
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA T Cell Antigen Gp39 Market Size (Million USD) by Region (2012-2022)
Figure Europe T Cell Antigen Gp39 Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe T Cell Antigen Gp39 Revenue (Million USD) Status and Forecast by Countries
Figure Middle East T Cell Antigen Gp39 Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East T Cell Antigen Gp39 Revenue (Million USD) Status and Forecast by Countries
Figure Africa T Cell Antigen Gp39 Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa T Cell Antigen Gp39 Revenue (Million USD) Status and Forecast by Countries
Figure EMEA T Cell Antigen Gp39 Sales Volume and Growth Rate (2012-2022)
Figure EMEA T Cell Antigen Gp39 Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA T Cell Antigen Gp39 Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA T Cell Antigen Gp39 Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA T Cell Antigen Gp39 Sales Share by Players (2012-2017)
Figure 2016 T Cell Antigen Gp39 Sales Share by Players
Figure 2017 T Cell Antigen Gp39 Sales Share by Players
Figure EMEA T Cell Antigen Gp39 Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA T Cell Antigen Gp39 Revenue (Million USD) by Players (2012-2017)
Table EMEA T Cell Antigen Gp39 Revenue Share by Players (2012-2017)
Table 2016 EMEA T Cell Antigen Gp39 Revenue Share by Players
Table 2017 EMEA T Cell Antigen Gp39 Revenue Share by Players
Table EMEA T Cell Antigen Gp39 Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA T Cell Antigen Gp39 Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA T Cell Antigen Gp39 Sales Share by Type (2012-2017)
Figure Sales Market Share of T Cell Antigen Gp39 by Type (2012-2017)
Figure EMEA T Cell Antigen Gp39 Sales Market Share by Type (2012-2017)
Table EMEA T Cell Antigen Gp39 Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA T Cell Antigen Gp39 Revenue Share by Type (2012-2017)
Figure Revenue Market Share of T Cell Antigen Gp39 by Type in 2016
Table EMEA T Cell Antigen Gp39 Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA T Cell Antigen Gp39 Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA T Cell Antigen Gp39 Sales Share by Application (2012-2017)
Figure Sales Market Share of T Cell Antigen Gp39 by Application (2012-2017)
Figure EMEA T Cell Antigen Gp39 Sales Market Share by Application in 2016
Table EMEA T Cell Antigen Gp39 Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA T Cell Antigen Gp39 Sales Share by Region (2012-2017)
Figure Sales Market Share of T Cell Antigen Gp39 by Region (2012-2017)
Figure EMEA T Cell Antigen Gp39 Sales Market Share in 2016
Table EMEA T Cell Antigen Gp39 Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA T Cell Antigen Gp39 Revenue Share by Region (2012-2017)
Figure Revenue Market Share of T Cell Antigen Gp39 by Region (2012-2017)
Figure EMEA T Cell Antigen Gp39 Revenue Market Share Regions in 2016
Table EMEA T Cell Antigen Gp39 Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe T Cell Antigen Gp39 Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe T Cell Antigen Gp39 Revenue and Growth Rate (2012-2017)
Table Europe T Cell Antigen Gp39 Sales (K Pcs) by Type (2012-2017)
Table Europe T Cell Antigen Gp39 Market Share by Type (2012-2017)
Figure Europe T Cell Antigen Gp39 Market Share by Type in 2016
Table Europe T Cell Antigen Gp39 Sales (K Pcs) by Application (2012-2017)
Table Europe T Cell Antigen Gp39 Market Share by Application (2012-2017)
Figure Europe T Cell Antigen Gp39 Market Share by Application in 2016
Table Europe T Cell Antigen Gp39 Sales (K Pcs) by Countries (2012-2017)
Table Europe T Cell Antigen Gp39 Sales Market Share by Countries (2012-2017)
Figure Europe T Cell Antigen Gp39 Sales Market Share by Countries (2012-2017)
Figure Europe T Cell Antigen Gp39 Sales Market Share by Countries in 2016
Table Europe T Cell Antigen Gp39 Revenue (Million USD) by Countries (2012-2017)
Table Europe T Cell Antigen Gp39 Revenue Market Share by Countries (2012-2017)
Figure Europe T Cell Antigen Gp39 Revenue Market Share by Countries (2012-2017)
Figure Europe T Cell Antigen Gp39 Revenue Market Share by Countries in 2016
Figure Germany T Cell Antigen Gp39 Sales (K Pcs) and Growth Rate (2012-2017)
Figure France T Cell Antigen Gp39 Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK T Cell Antigen Gp39 Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia T Cell Antigen Gp39 Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy T Cell Antigen Gp39 Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux T Cell Antigen Gp39 Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East T Cell Antigen Gp39 Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East T Cell Antigen Gp39 Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East T Cell Antigen Gp39 Sales (K Pcs) by Type (2012-2017)
Table Middle East T Cell Antigen Gp39 Market Share by Type (2012-2017)
Figure Middle East T Cell Antigen Gp39 Market Share by Type (2012-2017)
Table Middle East T Cell Antigen Gp39 Sales (K Pcs) by Applications (2012-2017)
Table Middle East T Cell Antigen Gp39 Market Share by Applications (2012-2017)
Figure Middle East T Cell Antigen Gp39 Sales Market Share by Application in 2016
Table Middle East T Cell Antigen Gp39 Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East T Cell Antigen Gp39 Sales Volume Market Share by Countries (2012-2017)
Figure Middle East T Cell Antigen Gp39 Sales Volume Market Share by Countries in 2016
Table Middle East T Cell Antigen Gp39 Revenue (Million USD) by Countries (2012-2017)
Table Middle East T Cell Antigen Gp39 Revenue Market Share by Countries (2012-2017)
Figure Middle East T Cell Antigen Gp39 Revenue Market Share by Countries (2012-2017)
Figure Middle East T Cell Antigen Gp39 Revenue Market Share by Countries in 2016
Figure Saudi Arabia T Cell Antigen Gp39 Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel T Cell Antigen Gp39 Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE T Cell Antigen Gp39 Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran T Cell Antigen Gp39 Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa T Cell Antigen Gp39 Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa T Cell Antigen Gp39 Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa T Cell Antigen Gp39 Sales (K Pcs) by Type (2012-2017)
Table Africa T Cell Antigen Gp39 Sales Market Share by Type (2012-2017)
Figure Africa T Cell Antigen Gp39 Sales Market Share by Type (2012-2017)
Figure Africa T Cell Antigen Gp39 Sales Market Share by Type in 2016
Table Africa T Cell Antigen Gp39 Sales (K Pcs) by Application (2012-2017)
Table Africa T Cell Antigen Gp39 Sales Market Share by Application (2012-2017)
Figure Africa T Cell Antigen Gp39 Sales Market Share by Application (2012-2017)
Table Africa T Cell Antigen Gp39 Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa T Cell Antigen Gp39 Sales Market Share by Countries (2012-2017)
Figure Africa T Cell Antigen Gp39 Sales Market Share by Countries (2012-2017)
Figure Africa T Cell Antigen Gp39 Sales Market Share by Countries in 2016
Table Africa T Cell Antigen Gp39 Revenue (Million USD) by Countries (2012-2017)
Table Africa T Cell Antigen Gp39 Revenue Market Share by Countries (2012-2017)
Figure Africa T Cell Antigen Gp39 Revenue Market Share by Countries (2012-2017)
Figure Africa T Cell Antigen Gp39 Revenue Market Share by Countries in 2016
Figure South Africa T Cell Antigen Gp39 Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria T Cell Antigen Gp39 Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt T Cell Antigen Gp39 Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria T Cell Antigen Gp39 Sales (K Pcs) and Growth Rate (2012-2017)
Table Biogen, Inc. T Cell Antigen Gp39 Basic Information List
Table Biogen, Inc. T Cell Antigen Gp39 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Biogen, Inc. T Cell Antigen Gp39 Sales (K Pcs) and Growth Rate (2012-2017)
Figure Biogen, Inc. T Cell Antigen Gp39 Sales Market Share in EMEA (2012-2017)
Figure Biogen, Inc. T Cell Antigen Gp39 Revenue Market Share in EMEA (2012-2017)
Table Bristol-Myers Squibb Company T Cell Antigen Gp39 Basic Information List
Table Bristol-Myers Squibb Company T Cell Antigen Gp39 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Company T Cell Antigen Gp39 Sales (K Pcs) and Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Company T Cell Antigen Gp39 Sales Market Share in EMEA (2012-2017)
Figure Bristol-Myers Squibb Company T Cell Antigen Gp39 Revenue Market Share in EMEA (2012-2017)
Table eTheRNA Immunotherapies NV T Cell Antigen Gp39 Basic Information List
Table eTheRNA Immunotherapies NV T Cell Antigen Gp39 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure eTheRNA Immunotherapies NV T Cell Antigen Gp39 Sales (K Pcs) and Growth Rate (2012-2017)
Figure eTheRNA Immunotherapies NV T Cell Antigen Gp39 Sales Market Share in EMEA (2012-2017)
Figure eTheRNA Immunotherapies NV T Cell Antigen Gp39 Revenue Market Share in EMEA (2012-2017)
Table ImmuNext, Inc. T Cell Antigen Gp39 Basic Information List
Table ImmuNext, Inc. T Cell Antigen Gp39 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure ImmuNext, Inc. T Cell Antigen Gp39 Sales (K Pcs) and Growth Rate (2012-2017)
Figure ImmuNext, Inc. T Cell Antigen Gp39 Sales Market Share in EMEA (2012-2017)
Figure ImmuNext, Inc. T Cell Antigen Gp39 Revenue Market Share in EMEA (2012-2017)
Table Juno Therapeutics Inc. T Cell Antigen Gp39 Basic Information List
Table Juno Therapeutics Inc. T Cell Antigen Gp39 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Juno Therapeutics Inc. T Cell Antigen Gp39 Sales (K Pcs) and Growth Rate (2012-2017)
Figure Juno Therapeutics Inc. T Cell Antigen Gp39 Sales Market Share in EMEA (2012-2017)
Figure Juno Therapeutics Inc. T Cell Antigen Gp39 Revenue Market Share in EMEA (2012-2017)
Table MedImmune, LLC T Cell Antigen Gp39 Basic Information List
Table MedImmune, LLC T Cell Antigen Gp39 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure MedImmune, LLC T Cell Antigen Gp39 Sales (K Pcs) and Growth Rate (2012-2017)
Figure MedImmune, LLC T Cell Antigen Gp39 Sales Market Share in EMEA (2012-2017)
Figure MedImmune, LLC T Cell Antigen Gp39 Revenue Market Share in EMEA (2012-2017)
Table Targovax AS T Cell Antigen Gp39 Basic Information List
Table Targovax AS T Cell Antigen Gp39 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Targovax AS T Cell Antigen Gp39 Sales (K Pcs) and Growth Rate (2012-2017)
Figure Targovax AS T Cell Antigen Gp39 Sales Market Share in EMEA (2012-2017)
Figure Targovax AS T Cell Antigen Gp39 Revenue Market Share in EMEA (2012-2017)
Table XL-protein GmbH T Cell Antigen Gp39 Basic Information List
Table XL-protein GmbH T Cell Antigen Gp39 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure XL-protein GmbH T Cell Antigen Gp39 Sales (K Pcs) and Growth Rate (2012-2017)
Figure XL-protein GmbH T Cell Antigen Gp39 Sales Market Share in EMEA (2012-2017)
Figure XL-protein GmbH T Cell Antigen Gp39 Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of T Cell Antigen Gp39
Figure Manufacturing Process Analysis of T Cell Antigen Gp39
Figure T Cell Antigen Gp39 Industrial Chain Analysis
Table Raw Materials Sources of T Cell Antigen Gp39 Major Manufacturers in 2016
Table Major Buyers of T Cell Antigen Gp39
Table Distributors/Traders List
Figure EMEA T Cell Antigen Gp39 Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA T Cell Antigen Gp39 Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA T Cell Antigen Gp39 Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA T Cell Antigen Gp39 Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA T Cell Antigen Gp39 Sales Market Share Forecast by Region (2017-2022)
Table EMEA T Cell Antigen Gp39 Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA T Cell Antigen Gp39 Revenue Market Share Forecast by Region (2017-2022)
Table Europe T Cell Antigen Gp39 Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe T Cell Antigen Gp39 Sales Market Share Forecast by Countries (2017-2022)
Table Europe T Cell Antigen Gp39 Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe T Cell Antigen Gp39 Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East T Cell Antigen Gp39 Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East T Cell Antigen Gp39 Sales Market Share Forecast by Countries (2017-2022)
Table Middle East T Cell Antigen Gp39 Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East T Cell Antigen Gp39 Revenue Market Share Forecast by Countries (2017-2022)
Table Africa T Cell Antigen Gp39 Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa T Cell Antigen Gp39 Sales Market Share Forecast by Countries (2017-2022)
Table Africa T Cell Antigen Gp39 Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa T Cell Antigen Gp39 Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA T Cell Antigen Gp39 Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA T Cell Antigen Gp39 Sales Market Share Forecast by Type (2017-2022)
Table EMEA T Cell Antigen Gp39 Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA T Cell Antigen Gp39 Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources